RÉSUMÉ
Mucormycosis is a rare life-threatening opportunistic infection, with rhinocerebral mucormycosis (ROCM) being the most common presentation. Trichosporon asahii is an emerging pathogen that often causes fatal infections in patients with underlying hematologic malignancies due to its high drug resistance. We report a rare case of concomitant rhinocerebral mucormycosis and T. asahii fungemia secondary to Pseudomonas aeruginosa sepsis in a patient with neutropenia and acute lymphoblastic leukemia. A boy aged one year and two months was diagnosed with B-cell acute lymphoblastic leukemia on January 10 and underwent three courses of regular chemotherapy. He experienced neutropenia for 154 days and was hospitalized for vomiting, diarrhea and fever for 3 days. The day after hospitalization, Pseudomonas aeruginosa was isolated by blood culture and ceftazidime/avibactam was administered. Extracorporeal Membrane Oxygenation (ECMO) was used to provide continuous extracorporeal respiration and circulation for the patient. On day 8, the patient developed T. asahii fungemia. On day 10, he presented with necrotizing skin caused by Rhizopus delemar. He was treated with liposomal amphotericin B for Rhizopus delemar and voriconazole for T. asahii infection. Unfortunately, his health deteriorated and he died on day 11 due to the rapid progression of the infection and multiple organ failure. The management and treatment of such a complex infection requires a multidisciplinary approach and close monitoring of the patient's condition. Therefore, it is imperative to continue to research and report rare cases such as this to further understand the complexities of mucormycosis and trichosporidiosis coinfection and improve patient outcomes.
Sujet(s)
Co-infection , Fongémie , Mucormycose , Leucémie-lymphome lymphoblastique à précurseurs B et T , Trichosporonose , Humains , Mâle , Mucormycose/complications , Mucormycose/diagnostic , Leucémie-lymphome lymphoblastique à précurseurs B et T/complications , Fongémie/microbiologie , Fongémie/traitement médicamenteux , Issue fatale , Co-infection/microbiologie , Trichosporonose/microbiologie , Trichosporonose/diagnostic , Trichosporonose/traitement médicamenteux , Nourrisson , Infections opportunistes/microbiologie , Infections opportunistes/complications , Infections à Pseudomonas/traitement médicamenteux , Infections à Pseudomonas/microbiologie , Infections à Pseudomonas/complications , Antifongiques/usage thérapeutique , BasidiomycotaRÉSUMÉ
COVID-19 disease is associated with a significant number of opportunistic infections, including invasive fungal infections such as mucormycosis. The prevalence of the latter is rare, estimated to be between 0.005 and 1.7 per million inhabitants. Risk factors include hematological diseases, Diabetes Mellitus with poor metabolic control, solid organ transplantation, neutropenia, and prolonged administration of systemic corticosteroids. We report two males aged 60 and 75 years with pulmonary and tracheobronchial invasive mucormycosis, respectively. Both patients had a deficient metabolic control of their diabetes as a predisposing risk factor added to severe COVID-19 infection. High suspicion and early diagnosis are essential for prompt treatment, especially considering the associated high morbidity and mortality of this fungal infection.
Sujet(s)
COVID-19 , Diabète , Mucormycose , Infections opportunistes , Humains , Mâle , COVID-19/complications , Mucormycose/complications , Mucormycose/diagnostic , Infections opportunistes/diagnostic , Infections opportunistes/complications , Facteurs de risque , Adulte d'âge moyen , Sujet âgéRÉSUMÉ
INTRODUCTION: Cryptococcosis is an opportunistic systemic mycosis caused by pathogenic encapsulated yeasts of the genus Cryptococcus. The objective of the present study was to evaluate the risk factors associated with death of patients diagnosed with meningitis due to Cryptococcus spp. METHODS: This retrospective cohort study included patients admitted to the São José Hospital (SJH) with Cryptococcal Meningoencephalitis (CM) who were diagnosed between 2010 and 2018. Data collection was carried out by reviewing the patients' medical records. Death during hospitalization was considered the primary outcome. RESULTS: From 2010 to 2018, 21,519 patients were admitted to the HSJ, 124 of whom were hospitalized due to CM. The CM incidence rate was 5.8 cases/103 hospitalizations. We included 112 patients in the study. Male patients were the most affected (82.1%), and the median age was 37 years [IQR: 29-45]. HIV coinfection occurred in 79.4% of the patients. Fever (65.2%) and headache (88.4%) were the most frequent symptoms. Greater cellularity in the CSF was the most related factor to CM in non-HIV individuals (p < 0.05). Death during hospitalization occurred in 28.6% (n = 32) of the patients. The independent risk factors associated with death during the hospitalization were women (p = 0.009), age > 35 years (p = 0.046), focal neurological deficits (p = 0.013), altered mental status (p = 0.018) and HIV infection (p = 0.040). The twelve-month survival was lower in HIV-positive patients (p < 0.05). CONCLUSION: Early diagnosis, optimal treatment, and clinical follow-up strategies, especially in HIV patients, should be prioritized.
Sujet(s)
Cryptococcose , Cryptococcus , Infections à VIH , Méningite cryptococcique , Méningoencéphalite , Infections opportunistes , Humains , Mâle , Femelle , Adulte , Infections à VIH/complications , Méningite cryptococcique/complications , Méningite cryptococcique/épidémiologie , Études rétrospectives , Brésil/épidémiologie , Facteurs de risque , Cryptococcose/épidémiologie , Hôpitaux , Méningoencéphalite/épidémiologie , Méningoencéphalite/complications , Infections opportunistes/complicationsRÉSUMÉ
COVID-19 disease is associated with a significant number of opportunistic infections, including invasive fungal infections such as mucormycosis. The prevalence of the latter is rare, estimated to be between 0.005 and 1.7 per million inhabitants. Risk factors include hematological diseases, Diabetes Mellitus with poor metabolic control, solid organ transplantation, neutropenia, and prolonged administration of systemic corticosteroids. We report two males aged 60 and 75 years with pulmonary and tracheobronchial invasive mucormycosis, respectively. Both patients had a deficient metabolic control of their diabetes as a predisposing risk factor added to severe COVID-19 infection. High suspicion and early diagnosis are essential for prompt treatment, especially considering the associated high morbidity and mortality of this fungal infection.
Sujet(s)
Humains , Mâle , Adulte d'âge moyen , Sujet âgé , Infections opportunistes/complications , Infections opportunistes/diagnostic , COVID-19/complications , Mucormycose/complications , Mucormycose/diagnostic , DiabèteRÉSUMÉ
La histoplasmosis diseminada es una infección oportunista frecuente en los pacientes VIH/sida. Frecuentemente se encuentra compromiso cutáneo, siendo las formas clínicas más comunes el aspecto moluscoide, variceliforme y papulonecrótico.Se presenta el caso de una paciente con una forma cutánea atípica de histoplasmosis diseminada similar a pioderma gangrenoso cuyo diagnóstico fue realizado mediante escarificación.Es importante mantener la sospecha clínica en estas presentaciones atípicas y reforzar la utilidad de la escarificación de lesiones cutáneas como método rápido y efectivo para su diagnóstico.
Disseminated histoplasmosis is a frequent opportunistic infection in HIV/AIDS patients. Cutaneous manifestations are common, the most frequent are molluscum contagio-sum-like lesions, varicelliform eruption and papulo-necro-tic lesions.We present a case of an atypical disseminated cutaneous histoplasmosis with pyoderma gangrenosum-like ulcers, diagnosed by direct examination of tissue smear.It is important to have a high clinical suspicion of this atypical presentation and to emphasize the usefulness of skin smear as a simple and effective test to establish its diagnosis
Sujet(s)
Humains , Femelle , Adulte , Ulcère cutané , Infections opportunistes/complications , VIH (Virus de l'Immunodéficience Humaine)/immunologie , Pyodermie phadégénique/diagnostic , Histoplasmose/diagnosticRÉSUMÉ
AIMS: This manuscript aims to explain the relationship between mucositis caused by 5-FU over gut bacterial species and susceptibility to opportunistic infection caused by P. aeruginosa. MAIN METHODS: BALB/c mice were intraperitoneally treated with PBS or 5-FU. Bodyweight and faecal consistency were checked daily. Mice faecal DNA was extracted, and bacterial phylogenetic groups were analysed using qPCR or high-throughput sequencing. Immunofluorescence was used to evaluate BMDM activation by mice-treated faecal content. Mice were challenged intratracheally with virulent P. aeruginosa, and the CFU and histology were analysed. Faecal microbiota were transplanted to evaluate the gut microbiota and resistance to pulmonary P. aeruginosa recovery. KEY FINDINGS: The animals treated with 5-FU presented mucositis with great weight loss, altered faecal consistency, bacterial gut dysbiosis and histological changes in the intestinal mucosa. Mice under 5-FU treatment were more susceptible to lung infection by the bacteria P. aeruginosa and had more extensive tissue damage during their lung infection with greater pro-inflammatory gene expression. It was observed that the mucositis remained in the groups with 5-FU even with the FMT. The results caused by mucositis in animals that received allogeneic FMT were reversed, however, with a decrease in P. aeruginosa susceptibility in animals treated with 5-FU and allogeneic FMT compared to animals treated with 5-FU and autologous FMT. SIGNIFICANCE: Treatment with 5-FU in a murine model makes it more susceptible to pulmonary infection by the bacterium P. aeruginosa, FMT offers an opportunity to protect against this susceptibility to infection.
Sujet(s)
Antinéoplasiques , Inflammation muqueuse , Infections opportunistes , Infections à Pseudomonas , Animaux , Antinéoplasiques/usage thérapeutique , Bactéries , Dysbiose/microbiologie , Fluorouracil/métabolisme , Muqueuse intestinale/métabolisme , Souris , Souris de lignée BALB C , Inflammation muqueuse/induit chimiquement , Inflammation muqueuse/traitement médicamenteux , Infections opportunistes/complications , Infections opportunistes/métabolisme , Infections opportunistes/anatomopathologie , Phylogenèse , Infections à Pseudomonas/traitement médicamenteux , Pseudomonas aeruginosaRÉSUMÉ
El virus de inmunodeficiencia humana (VIH)/ síndrome de inmunodeficiencia adquirida (SIDA), afecta a millones de personas alre-dedor del mundo. En Latinoamérica y el Caribe, casi 1.9 millones de personas viven con VIH/SIDA. Se caracteriza por ser una enfermedad multisistémica en donde las enfermedades oftalmológicas se presentan en un 70% a 80% de los pacientes infecta-dos. En estos pacientes las infecciones oportunistas son la principal causa de enfer-medad ocular sin embargo, es también causa de anomalías visuales, como la ano-malía de Peter que solo se presenta 1 en un millón de personas y es la causa de más del 40% de las opacidades corneales congéni-tas. Se presenta caso de femenina de 21 años de edad, procedente de San Pedro Sula, con antecedente de virus de inmuno-deficiencia adquirida en estadio B2, por transmisión vertical, en tratamiento con anti-rretrovirales, sin antecedentes maternos infecciosos sumados al VIH. Con historia de visión borrosa, lejana y cercana en ambos ojos con mayor severidad en ojo derecho. Además, refiere cefalea, frontal, pulsátil, de predominio vespertino que se irradia hacia parietal y occipital. Al exámen físico se encuentra agudeza visual disminuida, presión intraocular en límite superior, leuco-mas corneales y gonioscopía alterada en ambos ojos. Actualmente ambos ojos esta-bles y agudeza visual mejora con gradua-ción lo que es indicativo de un pronóstico favorable...(AU)
Sujet(s)
Humains , Femelle , Adulte , Rétinite/complications , Infections opportunistes/complications , VIH (Virus de l'Immunodéficience Humaine) , Malformations oculaires , Syndrome d'immunodéficience acquiseRÉSUMÉ
The small lymphocytic lymphoma is a mature B cell neoplasm with a broad spectrum of clinical presentations. Opportunistic infections that are not related to the treatment, even in advanced stages, have a low incidence rate. There are few case reports in the medical literature of patients who have not received immunosuppressive therapy and present with small lymphocytic lymphoma associated with disseminated histoplasmosis at diagnosis. A female 82-year-old patient was admitted due to an intermittent dry cough, asthenia, and adynamia that had persisted for one month. Multiple studies to detect infections and immuno-rheumatic conditions were performed and an extensive cervical, thoracic and peritoneal adenopathic syndrome was diagnosed. A flow cytometry and a cervical lymph node biopsy were performed reporting CD19+, CD20dim, CD5+, CD45+, CD23+, CD43neg, and CD10neg phenotypes with restriction in the light kappa chain compatible with a small lymphocytic lymphoma. Epithelioid granulomas without necrosis were observed in the lymph node histopathology and special colorations showed no microorganisms. The culture from the lymph node was positive for Histoplasma capsulatum. We initiated treatment with amphotericin B and itraconazole with an adequate response. In the absence of compliance with oncology treatment criteria, the patient was managed on a "watch and wait" basis. Opportunistic infections could be the initial clinical manifestation in patients with low-grade lymphoproliferative syndromes. This case report shows that they can develop even in the absence of chemotherapy.
Sujet(s)
Histoplasmose/complications , Leucémie chronique lymphocytaire à cellules B/diagnostic , Infections opportunistes/complications , Sujet âgé de 80 ans ou plus , Maladie d'Alzheimer/complications , Amphotéricine B/usage thérapeutique , Antifongiques/usage thérapeutique , Diabète de type 2/complications , Femelle , Histoplasma/isolement et purification , Histoplasmose/diagnostic , Histoplasmose/traitement médicamenteux , Humains , Hypertension artérielle/complications , Itraconazole/usage thérapeutique , Leucémie chronique lymphocytaire à cellules B/complications , Noeuds lymphatiques/imagerie diagnostique , Noeuds lymphatiques/microbiologie , Noeuds lymphatiques/anatomopathologie , Infections opportunistes/diagnostic , Infections opportunistes/traitement médicamenteux , Observation (surveillance clinique)RÉSUMÉ
RESUMEN El linfoma linfocítico de células pequeñas es una neoplasia de células B maduras con un amplio espectro de presentaciones clínicas. Las infecciones por gérmenes oportunistas no asociadas con el tratamiento, incluso en estadios avanzados de la enfermedad, tienen baja incidencia. Se han reportado muy pocos casos de pacientes con linfoma linfocítico de células pequeñas asociado a histoplasmosis diseminada que no habían recibido quimioterapia en el momento del diagnóstico. Se presenta el caso de una paciente de 82 años que fue hospitalizada por presentar tos seca intermitente, astenia y adinamia de un mes de evolución. Se le practicaron múltiples estudios para detectar infecciones o compromiso inmunológico o reumático, y se diagnosticó un síndrome adenopático extenso con compromiso cervical, torácico y retroperitoneal. En la citometría de flujo y en la biopsia de ganglio linfático cervical, se reportaron los fenotipos CD19+, CD20dim, CD5+, CD45+, CD23+, CD43neg y CD10neg, con restricción de la cadena ligera kappa, lo cual confirmó un linfoma linfocítico de células pequeñas. En la histopatología del ganglio, se observaron granulomas epitelioides sin necrosis, pero las coloraciones especiales no mostraron la presencia de microorganismos, en tanto que el cultivo del ganglio fue positivo para Histoplasma capsulatum. Se inició el tratamiento antifúngico con anfotericina B e itraconazol, y la paciente tuvo una adecuada evolución. Dado que no se cumplían los criterios para el tratamiento oncológico, se continuó con su observación mediante controles periódicos. Las infecciones oportunistas pueden ser la manifestación clínica inicial en pacientes con síndromes linfoproliferativos de bajo grado. Este caso demuestra que pueden desarrollarse, incluso, en ausencia de quimioterapia.
ABSTRACT The small lymphocytic lymphoma is a mature B cell neoplasm with a broad spectrum of clinical presentations. Opportunistic infections that are not related to the treatment, even in advanced stages, have a low incidence rate. There are few case reports in the medical literature of patients who have not received immunosuppressive therapy and present with small lymphocytic lymphoma associated with disseminated histoplasmosis at diagnosis. A female 82-year-old patient was admitted due to an intermittent dry cough, asthenia, and adynamia that had persisted for one month. Multiple studies to detect infections and immuno-rheumatic conditions were performed and an extensive cervical, thoracic and peritoneal adenopathic syndrome was diagnosed. A flow cytometry and a cervical lymph node biopsy were performed reporting CD19+, CD20dim, CD5+, CD45+, CD23+, CD43neg, and CD10neg phenotypes with restriction in the light kappa chain compatible with a small lymphocytic lymphoma. Epithelioid granulomas without necrosis were observed in the lymph node histopathology and special colorations showed no microorganisms. The culture from the lymph node was positive for Histoplasma capsulatum. We initiated treatment with amphotericin B and itraconazole with an adequate response. In the absence of compliance with oncology treatment criteria, the patient was managed on a "watch and wait" basis. Opportunistic infections could be the initial clinical manifestation in patients with low-grade lymphoproliferative syndromes. This case report shows that they can develop even in the absence of chemotherapy.
Sujet(s)
Sujet âgé de 80 ans ou plus , Femelle , Humains , Infections opportunistes/complications , Leucémie chronique lymphocytaire à cellules B/diagnostic , Histoplasmose/complications , Infections opportunistes/diagnostic , Infections opportunistes/traitement médicamenteux , Leucémie chronique lymphocytaire à cellules B/complications , Amphotéricine B/usage thérapeutique , Itraconazole/usage thérapeutique , Diabète de type 2/complications , Observation (surveillance clinique) , Maladie d'Alzheimer/complications , Histoplasma/isolement et purification , Histoplasmose/diagnostic , Histoplasmose/traitement médicamenteux , Hypertension artérielle/complications , Noeuds lymphatiques/microbiologie , Noeuds lymphatiques/anatomopathologie , Noeuds lymphatiques/imagerie diagnostique , Antifongiques/usage thérapeutiqueRÉSUMÉ
OBJECTIVE: To describe the distribution of pneumococcal serotypes causing infectious diseases in patients with hematological malignancies and solid tumors and their antimicrobial susceptibility before and after introduction of pneumococcal conjugate vaccine (PCV7) in Mexico. MATERIALS AND METHODS: Consecutive pneumococcal isolates from hospitalized patients from the SIREVA-network were serotyped using the Quellung reaction and antimicrobial susceptibility was performed using the broth microdilution method. RESULTS: A total of 175 pneumococcal isolates were recovered, 105 from patients with hematological malignancies and 70 with solid tumors. Serotypes 19A (22.7%), 19F (20.4%), and 35B (17.7%) were the most frequent isolates in the first group and serotypes 3 (27.2%) and 19A (28.6%) in the second group. No decreased susceptibility to beta-lactams or TMP/SMX was observed after introduction of PCV7. CONCLUSIONS: An increase in non-vaccine types is observed without significate changes in antimicrobial susceptibility after introduction of PCV7.
Sujet(s)
Infection croisée/microbiologie , Infections opportunistes/microbiologie , Infections à streptocoques/microbiologie , Streptococcus pneumoniae/isolement et purification , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Enfant , Enfant d'âge préscolaire , Infection croisée/épidémiologie , Multirésistance bactérienne aux médicaments , Femelle , Vaccin antipneumococcique conjugué heptavalent , Humains , Sujet immunodéprimé , Mâle , Mexique/épidémiologie , Adulte d'âge moyen , Tumeurs/complications , Infections opportunistes/complications , Infections opportunistes/épidémiologie , Sérogroupe , Infections à streptocoques/complications , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/effets des médicaments et des substances chimiques , Vaccination , Jeune adulteRÉSUMÉ
BACKGROUND AND OBJECTIVES: As for all tests, the diagnostic performances of Xpert MTB/RIF might be different in settings with different tuberculosis prevalence. Aim of the study is to evaluate the performances of Xpert MTB/RIF to diagnose tuberculosis in Brazil, where 407 culture-confirmed tuberculosis patients were retrospectively enrolled in Rio Grande do Sul, between 2015 and 2016. METHODS: Sensitivity, specificity, positive and negative predictive values of the test were calculated and a logistic regression analysis was performed to assess the role played by explanatory variables in the occurrence of true positive and negative diagnostic results. RESULTS: Sensitivity of Xpert MTB/RIF was 100.0%, specificity 92.8%; positive and negative predictive values were 71.4% and 100.0%, respectively. In the HIV- infected sub-group specificity was 59.3%. In the multivariate logistic regression analysis, true positivity was associated with increasing age (1.0; p-value: 0.02) while true positivity and negativity were negatively associated with alcohol abuse. CONCLUSIONS: Xpert is sensitive and specific in the Brasilian settings.
Sujet(s)
RT-PCR/méthodes , Tuberculose/diagnostic , Adulte , Antibiotiques antituberculeux/pharmacologie , Brésil , Co-infection , Résistance bactérienne aux médicaments , Femelle , Infections à VIH/complications , Humains , Mâle , Tests de sensibilité microbienne , Adulte d'âge moyen , Mycobacterium tuberculosis/effets des médicaments et des substances chimiques , Mycobacterium tuberculosis/isolement et purification , Infections opportunistes/complications , Infections opportunistes/diagnostic , Valeur prédictive des tests , Études rétrospectives , Rifampicine/pharmacologie , Sensibilité et spécificité , Tuberculose/complicationsRÉSUMÉ
PURPOSE: Bloodstream infections (BSIs) are an important cause of mortality in patients with solid tumors. We conducted a retrospective study to evaluate the epidemiologic profile and mortality of patients with solid tumors who have BSIs and were admitted to Mexico Hospital. This is the first study in Costa Rica and Central America describing the current epidemiologic situation. METHODS: We analyzed the infectious disease database for BSIs in patients with solid tumors admitted to Mexico Hospital from January 2012 to December 2014. Epidemiology and mortality were obtained according to microorganism, antibiotic sensitivity, tumor type, and presence of central venous catheter (CVC). Descriptive statistics were used. RESULTS: A total of 164 BSIs were recorded, the median age was 58 years, 103 patients (63%) were males, and 128 cases of infection (78%) were the result of gram-negative bacilli (GNB). Klebsiella pneumoniae (21%), Escherichia coli (21%), and Pseudomonas aeruginosa (15%) were the most common microorganisms isolated. Gram-positive cocci (GPC) were found in 36 patients, with the most frequent microorganisms being Staphylococcus aureus (10%) and Staphyloccocus epidermidis (6%). With respect to tumor type, BSIs were more frequent in the GI tract (57%) followed by head and neck (9%) and genitourinary tract (8%). Regarding antibiotic susceptibility, only 17% (GNB) expressed extended-spectrum beta-lactamase and 12% (GPC) had methicillin resistance. Patients with CVCs (n = 59) were colonized mainly by GNB (78%). Overall the mortality rate at 30 days was about 30%. CONCLUSION: GNB are the most frequent cause of BSIs in solid tumors and in patients with CVCs. GI cancers had more BSIs than other sites. Mortality and antibiotic sensitivity remained stable and acceptable during this observational period in this Latin American population.
Sujet(s)
Tumeurs/épidémiologie , Infections opportunistes/épidémiologie , Sepsie/épidémiologie , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Voies veineuses centrales/effets indésirables , Voies veineuses centrales/microbiologie , Costa Rica/épidémiologie , Infection croisée/complications , Infection croisée/épidémiologie , Infection croisée/microbiologie , Bases de données factuelles , Femelle , Infections bactériennes à Gram négatif/complications , Infections bactériennes à Gram négatif/épidémiologie , Infections bactériennes à Gram négatif/microbiologie , Hospitalisation/statistiques et données numériques , Humains , Mâle , Tests de sensibilité microbienne , Adulte d'âge moyen , Tumeurs/complications , Infections opportunistes/complications , Infections opportunistes/microbiologie , Pronostic , Études rétrospectives , Sepsie/complications , Sepsie/microbiologie , Jeune adulteRÉSUMÉ
Disseminated toxoplasmosis is a life-threatening disease in immunocompromised individuals. Infection is contracted from handling contaminated soil, cat litter, or through the consumption of contaminated water or food. It is the third most common lethal foodborne infection in the United States. In transplant patients, most cases occur as a result of reactivation of a latent infection resulting from immunosuppression. We present a case of disseminated toxoplasmosis diagnosed at the time of autopsy. This case emphasizes the importance of maintaining a high index of clinical suspicion and active disease surveillance in this era of sophisticated diagnostic testing.
Sujet(s)
Humains , Mâle , Adulte d'âge moyen , Infections opportunistes/complications , Toxoplasmose/complications , Receveurs de transplantation , Allogreffes , Autopsie , Issue fatale , Arrêt cardiaque/étiologie , Immunosuppression thérapeutique , Transplantation rénale/effets indésirables , Insuffisance respiratoire/étiologie , Toxoplasmose/diagnostic , Toxoplasmose/anatomopathologieRÉSUMÉ
There are very few reports of pediatric patients with infections by dematiaceous filamentous fungi. In this publication we report a case of invasive fungal infection of the nasal septum by Curvularia spicifera in a pediatric patient with acute myeloid leukemia. The patient presented with a painful scabby wound in the nasal vestibule. Culture and universal PCR were consistent with Curvularia spicifera. Early management with surgical debridement and bi-associated antifungal therapy achieved complete resolution of the lesions, with no evidence of dissemination and relapses. Clinical management of these fungal infections represents a challenge as the antifungal selection and duration of therapy is not yet well stablished.
Sujet(s)
Ascomycota/isolement et purification , Leucémie aigüe myéloïde/complications , Neutropénie/complications , Maladies du nez/complications , Infections opportunistes/complications , Phaeohyphomycose/complications , Enfant , Humains , Leucémie aigüe myéloïde/microbiologie , Mâle , Neutropénie/microbiologie , Maladies du nez/microbiologie , Infections opportunistes/microbiologie , Phaeohyphomycose/microbiologieRÉSUMÉ
We assessed the diagnostic ability of an enzyme-linked immunosorbent assay test for measurement of specific secretory IgA (sIgA) in saliva to identify cystic fibrosis (CF) patients with Pseudomonas aeruginosa chronic lung infection and intermittent lung colonization. A total of 102 Brazilian CF patients and 53 healthy controls were included. Specific serum IgG response was used as a surrogate to distinguish CF patients according to their P. aeruginosa colonization/infection status. The rate of sIgA positivity was 87.1% in CF chronically infected patients (median value = 181.5 U/mL), 48.7% in intermittently colonized patients (median value = 45.8 U/mL) and 21.8% in free of infection patients (median value = 22.1 U/mL). sIgA levels in saliva were significantly associated with serum P. aeruginosa IgG and microbiological culture results. The sensitivity, specificity, PPV and NPV for differentiation between presence and absence of chronic lung infection were 87%, 63%, 51% and 92%, respectively. Measurement of sIgA in saliva may be used for screening patients in risk of developing P. aeruginosa chronic lung infection in CF and possibly also for paranasal sinusitis, and, most importantly, to efficiently rule out chronic P. aeruginosa lung infection.
Sujet(s)
Anticorps antibactériens/analyse , Mucoviscidose/diagnostic , Immunoglobuline A sécrétoire/analyse , Immunoglobuline G/analyse , Infections opportunistes/diagnostic , Infections à Pseudomonas/diagnostic , Salive/composition chimique , Adolescent , Adulte , Études cas-témoins , Enfant , Enfant d'âge préscolaire , Études transversales , Mucoviscidose/complications , Mucoviscidose/immunologie , Mucoviscidose/microbiologie , Test ELISA , Femelle , Humains , Poumon/immunologie , Poumon/microbiologie , Poumon/anatomopathologie , Mâle , Infections opportunistes/complications , Infections opportunistes/immunologie , Infections opportunistes/microbiologie , Infections à Pseudomonas/complications , Infections à Pseudomonas/immunologie , Infections à Pseudomonas/microbiologie , Pseudomonas aeruginosa , Salive/immunologie , Salive/microbiologie , Sensibilité et spécificitéRÉSUMÉ
There are very few reports of pediatric patients with infections by dematiaceous filamentous fungi. In this publication we report a case of invasive fungal infection of the nasal septum by Curvularia spicifera in a pediatric patient with acute myeloid leukemia. The patient presented with a painful scabby wound in the nasal vestibule. Culture and universal PCR were consistent with Curvularia spicifera. Early management with surgical debridement and bi-associated antifungal therapy achieved complete resolution of the lesions, with no evidence of dissemination and relapses. Clinical management of these fungal infections represents a challenge as the antifungal selection and duration of therapy is not yet well stablished.
Existen pocos reportes de infecciones por hongos dematiáceos en pediatría. Comunicamos el caso de una infección fúngica invasora del tabique nasal en un niño con una leucemia mieloide aguda, que se presentó como una lesión costrosa dolorosa en el vestíbulo nasal. Se realizó desbridamiento quirúrgico precoz y recibió tratamiento antifúngico biasociado, lográndose resolución completa de las lesiones, sin diseminación ni recaídas. El cultivo y la RPC universal fueron compatibles con Curvularia spicifera. El manejo de estas infecciones fúngicas representa un desafío, considerando que la elección del agente antifúngico y la duración de la terapia no están completamente establecidas.
Sujet(s)
Humains , Mâle , Enfant , Ascomycota/isolement et purification , Infections opportunistes/complications , Leucémie aigüe myéloïde/complications , Maladies du nez/complications , Phaeohyphomycose/complications , Neutropénie/complications , Infections opportunistes/microbiologie , Leucémie aigüe myéloïde/microbiologie , Maladies du nez/microbiologie , Phaeohyphomycose/microbiologie , Neutropénie/microbiologieRÉSUMÉ
Opportunistic infections can cause manifestations that resemble neuropsychiatric systemic lupus erythematosus and they can also trigger lupus flares. Therefore, central nervous system infections as differential diagnosis in neuropsychiatric systemic lupus erythematosus may be difficult, leading to delayed diagnosis and specific treatment. Central nervous system infection in systemic lupus erythematosus is not common but, if left misdiagnosed and not treated promptly, can be fatal. Complementary diagnosis tests are generally non-specific and disappointing. Caution with immunosuppressive drug treatment should be emphasized while an opportunistic infection cannot be ruled out. In this review, we discuss the various types of central nervous system infections reported in systemic lupus erythematosus patients, highlighting the importance of their early recognition in order to improve morbidity and mortality. Prevention with vaccination is a recommended approach.
Sujet(s)
Maladies du système nerveux central/microbiologie , Lupus érythémateux disséminé/traitement médicamenteux , Vascularite lupique du système nerveux central/diagnostic , Infections opportunistes/diagnostic , Diagnostic différentiel , Diagnostic précoce , Femelle , Humains , Immunosuppresseurs/effets indésirables , Immunosuppresseurs/usage thérapeutique , Lupus érythémateux disséminé/complications , Mâle , Infections opportunistes/complications , Aggravation transitoire des symptômesRÉSUMÉ
BACKGROUND AND AIM: Although the esophagus is a common site of opportunistic infection in AIDS patients, little is known about the impact of HIV as well as opportunistic infection in the esophageal mucosa. Our aim is to analyze the esophageal immune profile in HIV+ patients with different immunological status with and without the opportunistic Candida infection. METHODS: Immunohistochemistry to CD4+ and CD8+ T-cells, γ-interferon, transforming growth factor-ß, interleukin (IL)-4, IL-6, IL-13, and IL-17 was performed in esophageal samples of 40 chronically HIV+ patients under highly active antiretroviral therapy (16 with Candida esophagitis, 12 virologically non-supressed with blood CD4 count < 500, and 12 virologically suppressed with blood CD4 count > 500; the latter two groups without esophageal candidiasis). The controls were 12 HIV-negative healthy individuals. RESULTS: Esophageal CD4+ T-cell expression in HIV+ patients did not differ from the control group (P = 0.50). Mucosal CD8+ T-cell expression was significantly increased in HIV+ patients (P = 0.0018). Candida esophagitis and virologically non-supressed HIV+ patients with CD4 < 500 showed an increased expression of IL-17 and IL-6 with fewer expressions of γ-interferon, more attenuated in the latter group. Transforming growth factor-ß was increased only in virologically suppressed HIV+ patients with CD4 > 500. IL-4 and IL-13 were similar to the control group. CONCLUSION: In contrast to CD8+ T-cell expression, esophageal CD4+ T-cell expression does not reflect the HIV+ patient's immunological status. T-helper 17 (Th17) response seems to play a role in the esophageal mucosa of virologically non-supressed HIV+ patients with blood CD4 < 500. Candida esophagitis showed a Th1/Th17 response but seems to be dominantly regulated by the Th17 pathway.
Sujet(s)
Candidose/complications , Muqueuse oesophagienne/immunologie , Oesophagite/microbiologie , Infections à VIH/complications , Infections opportunistes/complications , Adulte , Lymphocytes T CD4+ , Lymphocytes T CD8+ , Candidose/immunologie , Oesophagite/immunologie , Femelle , Infections à VIH/immunologie , Humains , Interleukine-17 , Interleukine-6 , Mâle , Adulte d'âge moyen , Infections opportunistes/immunologie , Facteur de croissance transformant bêtaRÉSUMÉ
Diabetes is a risk factor for the development of pulmonary tuberculosis (TB) and both diseases present endocrine alterations likely to play a role in certain immuno-endocrine-metabolic associated disorders. Patients with TB, or with TB and type 2 diabetes (TB + T2DM) and healthy controls (HCo) were assessed for plasma levels of cortisol, dehydroepiandrosterone (DHEA), estradiol, testosterone, growth hormone (GH), prolactin, insulin-like growth factor-1 (IGF-1), cytokines (IL-6, IL-10, IFN-γ) and the specific lymphoproliferative capacity of peripheral blood mononuclear cells. All patients had higher levels of cortisol with a reduction in DHEA, thus resulting in an increased cortisol/DHEA ratio (Cort/DHEA). Increased prolactin and particularly GH levels were found in both groups of TB patients. This was not paralleled by increased concentrations of IGF, which remained within the levels of HCo. Estradiol levels were significantly augmented in patients TB, and significantly more in TB + T2DM, whereas testosterone levels were decreased in both groups of patients. IFN- γ and IL-6 concentrations were significantly increased in all TB, even further in TB + T2DM; while IL-10 was equally increased in both groups of TB patients. The in vitro specific proliferative capacity was decreased in both groups of patients as compared to that of HCo. The adverse immune-endocrine profile of TB seems to be slightly more pronounced in patients who also have T2DM.
Sujet(s)
Cytokines/sang , Diabète de type 2/sang , Hormones/sang , Infections opportunistes/sang , Tuberculose pulmonaire/sang , Adulte , Études cas-témoins , Cellules cultivées , Diabète de type 2/complications , Diabète de type 2/immunologie , Femelle , Humains , Activation des lymphocytes , Mâle , Adulte d'âge moyen , Infections opportunistes/complications , Infections opportunistes/immunologie , Tuberculose pulmonaire/complications , Tuberculose pulmonaire/immunologieRÉSUMÉ
Introducción: el género Candida puede encontrarse colonizando el cuerpo humano, pero también puede provocar infecciones de carácter oportunista. La diabetes es considerada comúnmente un factor de riesgo para la infecciones candidósicas, dadas sus características asociadas a inmunosupresión, hiperglucemia, problemas de microvascularización, entre otros. Usualmente, para que se inicie un proceso infeccioso, es necesaria la colonización; por tanto, es importante conocer su frecuencia de portación en grupos con factores de riesgo asociados. Objetivo: determinar los porcentajes de colonización por Candida spp. en la cavidad oral y la zona interdigital del pie en pacientes diabéticos y no diabéticos. Métodos: el estudio, de carácter descriptivo, se realizó en un grupo de 85 pacientes del norte de Colombia: 46 diabéticos y 39 no diabéticos. La identificación de los aislamientos se realizó por pruebas fenotípicas, que incluyeron CHROMagar, microscopía, prueba de tubo germinal, prueba de clamidosporas y zimograma. Resultados: en los pacientes diabéticos se encontró una frecuencia de colonización por Candida spp. en la cavidad oral de 23,9 por ciento, y en el pie, de 56,52 por ciento; mientras que, para los sujetos no diabéticos, la frecuencia de colonización en la cavidad oral fue del 33,3 por ciento y en el pie del 43,58 por ciento. Adicionalmente, en el grupo de diabéticos se encontró que la frecuencia de colonización por la especie Candida albicans en la cavidad oral fue de 45,5 por ciento, mientras que en el pie fue del 11,5 por ciento. Conclusiones: los resultados obtenidos sugieren que las condiciones locales del ambiente de donde se aísla Candida spp. pueden influir en los niveles de portación y la variedad de especies, lo que podría ser más determinante que la condición de base(AU)
Introduction: Candida genus may colonize the human body but also may cause opportunistic infections. Diabetes is frequently considered a risk factor for Candida infections, given its characteristics associated to immunosuppresion, hyperglycemia, microvascularization problems and others. Generally, colonization is necessary for the starting of an infectious process; therefore, it is important to know its frequency of carriage in groups with associated risk factors. Objective: to determine the percentages of Candida spp. colonization in the oral cavity and the inter-toe area in diabetic and nondiabetic patients. Methods: the descriptive study was carried out in a group of 85 patients from the north of Colombia, that is, 46 diabetics and 39 non diabetics. The isolates were identified through phenotypical tests including CHROMagar, microscopy, germ tube test, Chlamydospore test and zymogram. Results: it was found in diabetic patients that the frequency of colonization by Candida spp. in the oral cavity was 23.9 percent and in the foot was 56.52 percent whereas in non-diabetic patients, the frequency of colonization in the oral cavity was 33.3 percent and in the foot was 43.58 percent. Additionally, it was found in the group of diabetic subjects that the frequency of colonization by Candida albicans was 45.5 percent in the oral cavity whereas that of the foot was 11.5 percent. Conclusions: the achieved results indicate that the local environmental conditions where the Candida spp. is isolated may have an impact on the levels of carriage and the variety of species, which could be more determining than the underlying condition(AU)